These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1306 related articles for article (PubMed ID: 9490916)
1. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Hoylaerts MF Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916 [TBL] [Abstract][Full Text] [Related]
2. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib. Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886 [TBL] [Abstract][Full Text] [Related]
3. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium. Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708 [TBL] [Abstract][Full Text] [Related]
5. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation. Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170 [TBL] [Abstract][Full Text] [Related]
6. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow? Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M Platelets; 2010; 21(2):101-11. PubMed ID: 20063990 [TBL] [Abstract][Full Text] [Related]
7. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster. Yamamoto H; Vreys I; Stassen JM; Yoshimoto R; Vermylen J; Hoylaerts MF Thromb Haemost; 1998 Jan; 79(1):202-10. PubMed ID: 9459348 [TBL] [Abstract][Full Text] [Related]
8. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388 [TBL] [Abstract][Full Text] [Related]
10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012 [TBL] [Abstract][Full Text] [Related]
11. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC Platelets; 2010; 21(4):244-52. PubMed ID: 20367574 [TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion. Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713 [TBL] [Abstract][Full Text] [Related]
13. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall]. Meyer D Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727 [TBL] [Abstract][Full Text] [Related]
15. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. Grainick HR; Williams SB; Coller BS J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249 [TBL] [Abstract][Full Text] [Related]
16. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor. Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543 [TBL] [Abstract][Full Text] [Related]
17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. de Romeuf C; Hilbert L; Mazurier C Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349 [TBL] [Abstract][Full Text] [Related]